Accéder au contenu
Merck

Glucocorticoid receptor function is decreased in neutrophils during endotoxic shock.

The Journal of infection (2014-03-25)
Maria Bergquist, Pernilla Jirholt, Merja Nurkkala, Christian Rylander, Göran Hedenstierna, Catharina Lindholm
RÉSUMÉ

It remains unclear whether glucocorticoid treatment can improve the outcome of sepsis. The aim of the present study was to investigate if glucocorticoid receptor (GR) expression and function is impaired in lipopolysaccharide (LPS) induced shock, and whether the time point for start of glucocorticoid treatment affects the outcome. Male C57BL/6J mice were administered LPS i.p. and GR expression and binding ability in blood and spleen leukocytes were analysed by flow cytometry. GR translocation was analysed using Image Stream technique. The effect of dexamethasone treatment started 2 h before or 2, 12 or 36 h after LPS administration on survival was studied. Despite increased GR expression in neutrophils after LPS administration, the GR binding capacity was reduced. In addition, GR translocation was decreased in neutrophils and T lymphocytes from endotoxic mice at 12 h compared to control animals. Dexamethasone treatment improved survival only when started early (2 h) after LPS administration. The decreased glucocorticoid responsiveness displayed by neutrophils, in combination with their increased numbers, may explain why survival is increased only when dexamethasone treatment is given early during LPS induced shock.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Dexaméthasone, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Dexaméthasone, ≥98% (HPLC), powder
Sigma-Aldrich
Dexaméthasone, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
USP
Dexaméthasone, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dexaméthasone, meets USP testing specifications
Supelco
Dexaméthasone, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Dexaméthasone, tested according to Ph. Eur.
Dexaméthasone, European Pharmacopoeia (EP) Reference Standard
Supelco
Dexaméthasone, VETRANAL®, analytical standard
Dexaméthasone, British Pharmacopoeia (BP) Assay Standard
Dexaméthasone, European Pharmacopoeia (EP) Reference Standard
Dexaméthasone, European Pharmacopoeia (EP) Reference Standard